Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Compass Div CODI Stock Hot on Social Media 875 20260420 The reasons Summit INN could be underpriced Nudges Down 20260511 ESP Espey Mfg notches 29 percent Q1 2026 EPS beat but shares drop 415 percent on soft investor sentiment SLF Sun Life posts Q4 2025 EPS beat and 115 percent annual revenue growth shares edge higher Target Corporation TGT New Chapter 5B Growth Strategy Targets Gen Z Wellness and Fandom Categories to Drive Sustained Turnaround Vanguard Real Estate ETF VNQ Named a Top Vanguard Dividend ETF for Reliable 2026 Passive Income How Selective SIGI is solving the problems its peers cannot 157 20260505 How CreativeMed CELZ prepares for market disruptions Q3 2025 Earnings Beat Estimates Materials Select Sector SPDR XLB Sector Performance Update Amid Broad Market RiskOff Sentiment and Geopolitical Uncertainty Core Labs CLB Q1 2026 Results Miss Estimates EPS 006 vs 011 Garrett Motion GTX Delivers Q1 2026 Beat EPS 049 vs 043 Expected Cronos CRON Reports Q1 2026 Results EPS 001 Meets Consensus Gentherm THRM Stock Jumps 118 Approaching 3205 20260518 The Federal Reserve Is Running Out of Convincing Reasons to Cut Interest Rates CCLDO Q1 2026 Earnings Slight EPS Miss as Company Reports Narrow Loss Geopolitical Risk Rises as IsraelHezbollah Conflict Death Toll Surpasses 3000 First Capital Inc FCAP Q1 2026 Earnings Solid EPS Delivery Amid Quiet Market Reaction HCAT Q1 2026 Earnings Earnings Beat Sentiment but Stock Slips FTK Q1 2026 Earnings EPS Misses Estimates Despite Slight Profit ASIX Q1 2026 Earnings Miss on EPS Stock Rises Despite Weakness GXAI Q1 2026 Earnings EPS Misses Estimates by 1765 Stock Declines ROKU Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment Xencor Inc XNCR Holds Near Support as Biotech Sector Shows Mixed Signals Velocity Financial VEL Declines Over 2 as Shares Test Key Support Levels Meridian Holdings Inc MRDN Edges Higher Testing Key Resistance Levels Teva Pharmaceuticals Advances 235 as Buyers Test Resistance Near 37 AVGO Q1 2026 Earnings Narrow EPS Miss Amid Modest Market Response EXPE Q1 2026 Earnings Strong EPS Beat Amid Revenue Uncertainty WLFC Q1 2026 Earnings EPS Surges Past Estimates with 354 Beat PRIM Q1 2026 Earnings EPS Misses Estimates by Over 31 Stock Edges Higher CLBT Q1 2026 Earnings Strong EPS Beat Highlights Profitability Improvement MHH Q1 2026 Earnings EPS Miss Disappoints Despite Positive Stock Movement